Literature DB >> 23379359

Association between age and high-risk human papilloma virus in Mexican oral cancer patients.

I González-Ramírez1, M E Irigoyen-Camacho, V Ramírez-Amador, M Lizano-Soberón, A Carrillo-García, A García-Carrancá, Y Sánchez-Pérez, R Méndez-Martínez, M Granados-García, Lm Ruíz-Godoy, Cm García-Cuellar.   

Abstract

OBJECTIVE: Studies reporting low prevalence of HPV in OSCC with declining age at presentation are increasing. The aim of this study was to determine the prevalence of HPV in a group of OSCC cases and controls in a Mexican population.
METHODS: The matched case-control study included 80 OSCC cases and 320 controls. HPV/DNA presence was evaluated through PCR amplification using three sets of consensus primers for the L1 gene. A conditional logistic regression analysis was carried out for the matched OSCC cases and controls. Interactions between risk factors and OCSS were tested in the construction process of the models.
RESULTS: HPV prevalence was 5% in OSCC cases and 2.5% in controls. HPV-detected types were 16, 18 and 56. According to conditional logistics regression model, an association was detected between HR-HPV and OSCC. All HR-HPV-positive OSCC cases corresponded to young patients (<45 years), non-smokers and non-alcohol drinkers.
CONCLUSIONS: The HR-HPV can be a contributing factor to oral carcinogenesis, especially in younger individuals without known risk factors such as tobacco and alcohol.
© 2013 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  human papillomavirus; oral squamous cell carcinoma; young patients

Mesh:

Year:  2013        PMID: 23379359     DOI: 10.1111/odi.12071

Source DB:  PubMed          Journal:  Oral Dis        ISSN: 1354-523X            Impact factor:   3.511


  8 in total

1.  XPD Lys751Gln polymorphism is not associated with oral cancer risk: evidence from a meta-analysis.

Authors:  Jing Cui; Dalu Li; Liang Shen; Wenmei Zhang; Xin Xu
Journal:  Tumour Biol       Date:  2014-03-22

2.  Prevalence of HPV in Oral Squamous Cell Carcinoma in South West India.

Authors:  Pooja Dalakoti; Balakrishnan Ramaswamy; Ajay M Bhandarkar; Dipak Ranjan Nayak; Sasidharanpillai Sabeena; Govindakarnavar Arunkumar
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2018-08-21

Review 3.  Non-coding RNAs deregulation in oral squamous cell carcinoma: advances and challenges.

Authors:  T Yu; C Li; Z Wang; K Liu; C Xu; Q Yang; Y Tang; Y Wu
Journal:  Clin Transl Oncol       Date:  2015-09-14       Impact factor: 3.405

4.  Correlation of human papilloma virus with oral squamous cell carcinoma in Chinese population.

Authors:  Jingping Zhou; Detao Tao; Daofang Tang; Zhenlin Gao
Journal:  Int J Clin Exp Med       Date:  2015-10-15

Review 5.  Role of human papillomavirus in oral squamous cell carcinoma and oral potentially malignant disorders: A review of the literature.

Authors:  Shikha Gupta; Sunita Gupta
Journal:  Indian J Dent       Date:  2015 Apr-Jun

6.  Prevalence of human papillomavirus16 DNA and p16INK4a protein in oral squamous cell carcinoma: A systematic review and meta-analysis.

Authors:  T Smitha; C V Mohan; S Hemavathy
Journal:  J Oral Maxillofac Pathol       Date:  2017 Jan-Apr

7.  Frequency of HPV in oral cavity squamous cell carcinoma.

Authors:  Priscila Marinho de Abreu; Anna Clara Gregório Có; Pedro Leite Azevedo; Isabella Bittencourt do Valle; Karine Gadioli de Oliveira; Sônia Alves Gouvea; Melissa Freitas Cordeiro-Silva; Iúri Drummond Louro; José Roberto Vasconcelos de Podestá; Jeferson Lenzi; Agenor Sena; Elismauro Francisco Mendonça; Sandra Lúcia Ventorin von Zeidler
Journal:  BMC Cancer       Date:  2018-03-27       Impact factor: 4.430

Review 8.  Evidence for different molecular parameters in head and neck squamous cell carcinoma of nonsmokers and nondrinkers: Systematic review and meta-analysis on HPV, p16, and TP53.

Authors:  Frans J Mulder; Damiana D C G Pierssens; Laura W J Baijens; Bernd Kremer; Ernst-Jan M Speel
Journal:  Head Neck       Date:  2020-10-23       Impact factor: 3.147

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.